NMTC

NeuroOne Medical Technologies Corporation

$0.78

-12.21%
SectorHealthcareIndustryMedical DevicesCountryUnited States

NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders. The company has a collaboration with the Department of Neurology's Division of Epilepsy at the University of Minnesota Medical School to advance a study evaluating epilepsy therapies. The company is based in Eden Prairie, Minnesota.

Source: Yahoo Finance
AI summary

Price & performance

1M-16.5%
3M-44.7%
YTD-81.7%
1Y-80.3%
52-week range—
Beta0.84
Full chart and returns against a benchmark

Q-Score

37/ 100

Quality against peers; 50 is the peer median.

Growth43
Risk43
Performance32
Valuation47
Profitability41
Leverage37
Sentiment76
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$9.1M+163.5%
Net income-$3.6M
Net margin-39.6%+317.1 pts
Historical fundamentals

Red flags in filings

3active red flags
Going-concern doubtDec 17, 2025
Material weakness in controlsDec 17, 2025
Restated financialsMay 22, 2026
Filings, findings and the timeline

Revenue exposure

0%of revenue from outside the US
United States100%
Largest customer97%
Regions, segments, customers and suppliers

Valuation

NMTCIndustryP/E—29.61P/S0.753.49EV/EBITDA—18.38P/B1.883.39PEG——
Dividend yield0.00%
Every valuation metric

Earnings

Dec 15next report
EPS estimate—
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate